InsidersTradesSigma
Discover the complete record of transactions filed by Masson-Hurlburt Elizabeth, Chief Operating Officer. Officer active across 1 companies, notably CorMedix Inc.. Cumulatively, 2 reports have been logged. Total volume traded: €91k. The latest transaction was filed on 21 May 2021 — Cession. Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Elizabeth Masson-Hurlburt is the Executive Vice President and Head of Clinical Operations at CorMedix Inc. She is responsible for overseeing clinical operations, ensuring that trials and studies meet quality and compliance standards. Her expertise is essential for the development of new treatments.